Home Cart Sign in  
Chemical Structure| 41964-07-2 Chemical Structure| 41964-07-2

Structure of Tolimidone
CAS No.: 41964-07-2

Chemical Structure| 41964-07-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tolimidone is an effective and selective Lyn kinase allosteric activator with an EC50 of 63 nM.

Synonyms: MLR-1023; CP 26,154; NSC 314335

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tolimidone

CAS No. :41964-07-2
Formula : C11H10N2O2
M.W : 202.21
SMILES Code : O=C1N=CC(OC2=CC=CC(C)=C2)=CN1
Synonyms :
MLR-1023; CP 26,154; NSC 314335
MDL No. :MFCD00866900

Safety of Tolimidone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Related Pathways of Tolimidone

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02317796 Type 2 Diabetes PHASE2 COMPLETED 2025-02-16 Melior Pharmaceuticals I & Buk... More >>wang Pharm. Co., Ltd., USA and South Korea, Pennsylvania, United States Less <<
NCT03279263 Type 2 Diabetes Mellitus Phase 2 Recruiting September 2019 United States, California ... More >> National Research Institute Recruiting Los Angeles, California, United States, 90057 Contact: Juan Frias, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.95mL

0.99mL

0.49mL

24.73mL

4.95mL

2.47mL

49.45mL

9.89mL

4.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories